Ameloblastoma natural history, complications and prognosis

Revision as of 21:05, 21 December 2015 by Simrat Sarai (talk | contribs)
Jump to navigation Jump to search

Ameloblastoma Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ameloblastoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ameloblastoma natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ameloblastoma natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ameloblastoma natural history, complications and prognosis

CDC on Ameloblastoma natural history, complications and prognosis

Ameloblastoma natural history, complications and prognosis in the news

Blogs on Ameloblastoma natural history, complications and prognosis

Directions to Hospitals Treating Ameloblastoma

Risk calculators and risk factors for Ameloblastoma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]

Overview

Natural History

Complications

According to World Health Organization (WHO) ameloblastoma is a benign tumor. Metastases to the lungs or central nervous system (CNS) have rarely been reported. Complications of ameloblastoma include the following:

  • Breathing difficulty
  • Pain and facial deformity
  • Secondary infection of the tumor
  • The recurrence rate of these tumors is 25-30%. The tumor can recur after treatment and hence, a close follow-up is needed.

Prognosis

References

Template:WH Template:WS